Runx2 in human breast carcinoma: its potential roles in cancer progression-Reference-Cited by-同舟云学术

Runx2 in human breast carcinoma: its potential roles in cancer progression

Published:2010-10-12 Issue:12 Volume:101 Page:2670-2675
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Onodera Yoshiaki,Miki Yasuhiro,Suzuki Takashi,Takagi Kiyoshi,Akahira Jun-ichi,Sakyu Takuya,Watanabe Mika,Inoue Satoshi,Ishida Takanori,Ohuchi Noriaki,Sasano Hironobu

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2010.01742.x/fullpdf

Reference51 articles.

1. Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?;Gnant;Clin Breast Cancer,2009

2. Evidence for a causal role of parathyroid hormonerelated protein in the pathogenesis of human breast cancer-mediated osteolysis;Guise;J Clin Invest,1996

3. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer;Burtis;N Engl J Med,1990

4. Immunohistochemical localization of parathyroid hormone-related protein in breast cancer;Southby;Cancer Res,1990

5. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo;Uy;Cancer Res,1997

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RUNX transcription factors: biological functions and implications in cancer;Clinical and Experimental Medicine;2024-03-02

2. Mesenchymal stem cell-derived exosomes enriched with miR-218 reduce the epithelial–mesenchymal transition and angiogenesis in triple-negative breast cancer cells;European Journal of Medical Research;2023-11-15

3. Prognostic Role of Prolactin-Induced Protein (PIP) in Breast Cancer;Cells;2023-09-11

4. The critical role of circular RNAs in drug resistance in gastrointestinal cancers;Medical Oncology;2023-03-14

5. RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells;Medical Oncology;2023-03-10